Health Sciences Acquisitions 2 shareholders approve merger with Orchestra BioMed; closing expected Jan 2023

Orchestra BioMed Holdings, Inc.

All 9 proposals approved at Jan 24 EGM, including Merger Agreement, Domestication, and Equity Incentive Plan.
Business Combination with Orchestra BioMed to close in January 2023, subject to remaining conditions.
Directors elected for New Orchestra: Eric Rose, Jason Aryeh, Pamela Connealy, Geoffrey Smith, David Hochman, Darren Sherman, Eric Fain.
Vote results: 9.44M for (96.5% of voting) on Business Combination Proposal; quorum of 87.2% achieved.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.